Shehab, H. M., & Yasmin, H. (2024). A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine. Brac University.
Παραπομπή σε μορφή Chicago (17η εκδ.)Shehab, Habibul Mohsin, και Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
Παραπομπή σε μορφή MLA (8th εκδ.)Shehab, Habibul Mohsin, και Hasina Yasmin. A Pharmacovigilance Study to Determine Risk of Mortality in Male and Female Patients with Alzheimer's Disease Using Rivastigmine. Brac University, 2024.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.